These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 9302150

  • 1. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A, Naber KG, Bischoff W, Kullmann K.
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [Abstract] [Full Text] [Related]

  • 2. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
    Iravani A.
    Am J Med; 1993 Mar 22; 94(3A):89S-96S. PubMed ID: 8452189
    [Abstract] [Full Text] [Related]

  • 3. Once Daily Fleroxacin and Twice Daily Ciprofloxacin are Both Effective in the Treatment of Complicated Urinary Tract Infections.
    Guimarães T, Rios LA, Mendes W, Brandina L, Silva NF, Bastos C, Alcântara AP, Levi G.
    Braz J Infect Dis; 1997 Apr 22; 1(2):77-82. PubMed ID: 11107243
    [Abstract] [Full Text] [Related]

  • 4. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A, Tice AD, McCarty J, Sikes DH, Nolen T, Gallis HA, Whalen EP, Tosiello RL, Heyd A, Kowalsky SF.
    Arch Intern Med; 1995 Mar 13; 155(5):485-94. PubMed ID: 7864704
    [Abstract] [Full Text] [Related]

  • 5. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ.
    Am J Med; 1993 Mar 22; 94(3A):105S-107S. PubMed ID: 8452164
    [Abstract] [Full Text] [Related]

  • 6. Comparison of intravenous fleroxacin with ceftazidime for treatment of complicated urinary tract infections.
    Cox CE.
    Am J Med; 1993 Mar 22; 94(3A):118S-125S. PubMed ID: 8452167
    [Abstract] [Full Text] [Related]

  • 7. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.
    Pittman W, Moon JO, Hamrick LC, Cox CE, Clark J, Childs S, Pizzuti D, Fredericks J, St Clair P.
    Am J Med; 1993 Mar 22; 94(3A):101S-104S. PubMed ID: 8452163
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
    Naber KG, Sigl G.
    Am J Med; 1993 Mar 22; 94(3A):114S-117S. PubMed ID: 8452166
    [Abstract] [Full Text] [Related]

  • 10. A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection.
    Gelfand MS, Simmons BP, Craft RB, Grogan J, Amarshi N.
    Am J Med; 1993 Mar 22; 94(3A):126S-130S. PubMed ID: 8452168
    [Abstract] [Full Text] [Related]

  • 11. [Comparative study on intravenous drip infusion of dibekacin once daily and twice daily in treatment of complicated urinary tract infections].
    Kishi H, Kaneco H, Tominaga T, Niijima T, Nishimura Y, Saito I, Ishii Y, Nito H, Yuge J, Asano M.
    Hinyokika Kiyo; 1984 Jan 22; 30(1):103-20. PubMed ID: 6375317
    [Abstract] [Full Text] [Related]

  • 12. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ.
    Am J Med; 1987 Apr 27; 82(4A):295-300. PubMed ID: 3555051
    [Abstract] [Full Text] [Related]

  • 13. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D.
    Int J Antimicrob Agents; 2004 Jun 27; 23(6):596-605. PubMed ID: 15194131
    [Abstract] [Full Text] [Related]

  • 14. Ciprofloxacin: an update on clinical experience.
    Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R.
    Am J Med; 1987 Apr 27; 82(4A):381-6. PubMed ID: 3555063
    [Abstract] [Full Text] [Related]

  • 15. Oral fleroxacin prophylaxis in transurethral surgery.
    Gasser TC, Wisard M, Frei R.
    J Urol; 1996 Jul 27; 156(1):146-8. PubMed ID: 8648777
    [Abstract] [Full Text] [Related]

  • 16. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S, Kollaras P, Giannakakis T, Seitanidis B, Kordosis T, Nikolaidis J, Hatzitolios A, Nikolaidis P.
    Eur J Intern Med; 2008 Dec 27; 19(8):619-24. PubMed ID: 19046729
    [Abstract] [Full Text] [Related]

  • 17. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky SF, Echols RM.
    J Antimicrob Chemother; 1999 Mar 27; 43 Suppl A():67-75. PubMed ID: 10225575
    [Abstract] [Full Text] [Related]

  • 18. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women.
    Melekos MD, Asbach HW, Gerharz E, Zarakovitis IE, Weingaertner K, Naber KG.
    J Urol; 1997 Mar 27; 157(3):935-9. PubMed ID: 9072603
    [Abstract] [Full Text] [Related]

  • 19. Complicated urinary infection in spinal injury patients: fleroxacin compared with ciprofloxacin.
    Whitby M, Angus L, Nimmo G, Hill V.
    Chemotherapy; 1996 Mar 27; 42(6):468-72. PubMed ID: 8957583
    [Abstract] [Full Text] [Related]

  • 20. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL, Figueroa-Damián R, Rosas A, Jáuregui A, Corral M, Costa A, Merlos RM, Ríos-Fabra A, Amábile-Cuevas CF, Hernández-Oliva GM, Olguín J, Cardeñosa-Guerra O, uUTI Latin American Study Group.
    J Antimicrob Chemother; 2004 Oct 27; 54(4):840-3. PubMed ID: 15347634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.